RVAC Medicines has signed a maestro probe concern statement with the Agency for Science, Technology and Research (A*STAR) for analysing and processing solutions to physique messenger ribonucleic acerb (mRNA) manufacturing and analytics expertise successful Singapore.
Under the partnership, the parties volition found a associated laboratory astatine the Bioprocessing Technology Institute (BTI) of A*STAR for processing a preclinical manufacturing platform.
This volition assistance successful the accumulation of caller earthy materials and imaginable clinical-grade assets to make mRNA vaccines and therapies for infectious diseases, arsenic good arsenic different ailments with unmet needs.
The confederation volition usage the capabilities of BTI successful processing technologies and analytical sciences for biotherapeutics, arsenic good arsenic robust translational probe successful biomedical technologies crossed assorted probe institutes successful A*STAR.
RVAC and A*STAR purpose to supply section ecosystem innovators and planetary manufacturers with entree to the accumulation level to enactment the improvement of a preclinical asset.
Additionally, the wide-ranging expertise of RVAC successful mRNA, vaccine and cause transportation technologies, and its capabilities successful probe and improvement (R&D), biopharmaceutical manufacturing, objective improvement and selling is leveraged nether the partnership.
RVAC is presently processing mRNA-based vaccines against infectious diseases specified arsenic Covid-19.
It commenced a first-in-human objective proceedings of the vaccines successful September this year.
Vaccines targeting respiratory syncytial microorganism (RSV) and Clostridioides difficile (CDI) infections are besides portion of RVAC’s pipeline of developmental assets.
RVAC Medicines CEO Dr Sean Fu said: “Our collaboration with A*STAR brings unneurotic innovative probe and improvement acquisition from immoderate of the world’s starring mRNA researchers.
“We are committed to providing the staff, instrumentality and technological expertise, with enactment from our R&D teams astir the world, to this endeavour.
“Combined with A*STAR’s cognition and experience, this concern has the imaginable to proceed the advancement of mRNA arsenic a caller people of medicines.”
Cell & Gene Therapy sum connected Pharmaceutical Technology is supported by Cytiva.
Editorial contented is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not progressive successful the instauration of editorial content.
Optimise your compartment therapy process: a usher to compartment thawing
Typically carried retired astatine the constituent of care, errors successful compartment therapy thawing could compromise attraction efficacy, starring to important diligent interaction arsenic good arsenic precocious costs and a compromised estimation for the product’s developer. This usher addresses however compartment thawing has historically developed into the caller techniques utilized today, on with the carnal and biologic implications of cardinal metrics and components specified arsenic warming complaint and crystal structure. Also included are reviews of cardinal studies from technological lit and a information of the interactions betwixt cooling and warming rates, arsenic applicable to compartment and cistron therapies.
By clicking the Download Free Whitepaper button, you judge the presumption and conditions and admit that your information volition beryllium utilized arsenic described successful the Cytiva Thematic privateness argumentation By downloading this Whitepaper, you admit that we whitethorn stock your accusation with our achromatic insubstantial partners/sponsors who whitethorn interaction you straight with accusation connected their products and services.
Visit our privacy policy for much accusation astir our services, however we whitethorn use, process and stock your idiosyncratic data, including accusation connected your rights successful respect of your idiosyncratic information and however you tin unsubscribe from aboriginal selling communications. Our services are intended for firm subscribers and you warrant that the email code submitted is your firm email address.